TORRENTE, YVAN
TORRENTE, YVAN
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Flvcr1a deficiency promotes heme-based energy metabolism dysfunction in skeletal muscle
2024 M. Mistretta, V. Fiorito, A.L. Allocco, G. Ammirata, M.Y. Hsu, S. Digiovanni, M. Belicchi, L. Napoli, M. Ripolone, E. Trombetta, P. Mauri, A. Farini, M. Meregalli, C. Villa, P.E. Porporato, B. Miniscalco, S.G. Crich, C. Riganti, Y. Torrente, E. Tolosano
Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive Review
2024 M. Molinaro, Y. Torrente, C. Villa, A. Farini
Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion
2024 A. Díaz-Basabe, G. Lattanzi, F. Perillo, C. Amoroso, A. Baeri, A. Farini, Y. Torrente, G. Penna, M. Rescigno, M. Ghidini, E. Cassinotti, L. Baldari, L. Boni, M. Vecchi, F. Caprioli, F. Facciotti, F. Strati
Exploring the Gut Microbiota–Muscle Axis in Duchenne Muscular Dystrophy
2024 D. Mostosi, M. Molinaro, S. Saccone, Y. Torrente, C. Villa, A. Farini
Editorial: Inflammation in muscular dystrophies: mediators, mechanisms, and therapeutics
2024 C. Villa, A. Farini, Y. Torrente
Magnetic-field-driven targeting of exosomes modulates immune and metabolic changes in dystrophic muscle
2024 C. Villa, V. Secchi, M. Macchi, L. Tripodi, E. Trombetta, D. Zambroni, F. Padelli, M. Mauri, M. Molinaro, R. Oddone, A. Farini, A. De Palma, L. Varela Pinzon, F. Santarelli, R. Simonutti, P. Mauri, L. Porretti, M. Campione, D. Aquino, A. Monguzzi, Y. Torrente
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification
2024 V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, G. Fabbiano, V. Traini, K. Todoerti, S. Erratico, A. Ciarrocchi, V. Fragliasso, D. Giannandrea, F. Tumiatti, R. Chiaramonte, Y. Torrente, P. Finelli, E. Morelli, N.C. Munshi, N. Bolli, A. Neri, E. Taìana
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma
2024 N. Puccio, G. Manzotti, E. Mereu, F. Torricelli, D. Ronchetti, M. Cumerlato, I. Craparotta, L.D. Rito, M. Bolis, V. Traini, V. Manicardi, V. Fragliasso, Y. Torrente, N. Amodio, N. Bolli, E. Taiana, A. Ciarrocchi, R. Piva, A. Neri
Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy
2024 F. Galli, L. Bragg, M. Rossi, D. Proietti, L. Perani, M. Bagicaluppi, R. Tonlorenzi, T. Sibanda, M. Caffarini, A. Talapatra, S. Santoleri, M. Meregalli, B. Bano-Otalora, A. Bigot, I. Bozzoni, C. Bonini, V. Mouly, Y. Torrente, G. Cossu
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases
2023 M. Mistretta, A. Farini, Y. Torrente, C. Villa
Combinatorial activation of the WNT-dependent fibrogenic program by distinct complement subunits in dystrophic muscle
2023 F. Florio, S. Vencato, F.T. Papa, M. Libergoli, E. Kheir, I. Ghzaiel, T.A. Rando, Y. Torrente, S. Biressi
Mesoangioblasts at 20: From the embryonic aorta to the patient bed
2023 G. Cossu, R. Tonlorenzi, S. Brunelli, M. Sampaolesi, G. Messina, E. Azzoni, S. Benedetti, S. Biressi, C. Bonfanti, L. Bragg, J. Camps, O. Cappellari, M. Cassano, F. Ciceri, M. Coletta, D. Covarello, S. Crippa, M.G. Cusella-De Angelis, L. De Angelis, A. Dellavalle, J. Diaz-Manera, D. Galli, F. Galli, C. Gargioli, M.F.M. Gerli, G. Giacomazzi, B.G. Galvez, H. Hoshiya, M. Guttinger, A. Innocenzi, M.G. Minasi, L. Perani, S.C. Previtali, M. Quattrocelli, M. Ragazzi, U. Roostalu, G. Rossi, R. Scardigli, D. Sirabella, F.S. Tedesco, Y. Torrente, G. Ugarte
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins
2023 E. Taiana, C. Bandini, V.K. Favasuli, D. Ronchetti, I. Silvestris, N. Puccio, K. Todoerti, S. Erratico, D. Giannandrea, N. Bolli, N. Amodio, A. Ciarrocchi, R. Chiaramonte, Y. Torrente, R. Piva, A. Neri
Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45–50 into an induced pluripotent stem cell line (CCMi005-A)
2022 D. Rovina, E. Castiglioni, S. Mallia, M. Rabino, A. Farini, M. Belicchi, G. Di Giuseppe, C.C.G. Gervasini, Y. Torrente, G. Pompilio, A. Gowran
Immunoproteasome Inhibition Ameliorates Aged Dystrophic Mouse Muscle Environment
2022 L. Tripodi, D. Molinaro, F.R. Fortunato, C. Mella, B. Cassani, Y. Torrente, A. Farini
Effective high-throughput isolation of enriched platelets and circulating pro-angiogenic cells to accelerate skin-wound healing
2022 S. Erratico, M. Belicchi, M. Meregalli, D. Di Silvestre, L. Tripodi, A. De Palma, R. Jones, E. Ferrari, L. Porretti, E. Trombetta, G.R. Merlo, P. Mauri, Y. Torrente
Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice
2022 A. Farini, L. Tripodi, C. Villa, F. Napolitano, F. Strati, D. Molinaro, F. Facciotti, B. Cassani, Y. Torrente
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice
2022 A. Farini, L. Tripodi, C. Villa, F. Strati, A. Facoetti, G.A. Baselli, J. Troisi, A. Landolfi, C. Lonati, D. Molinaro, M. Wintzinger, S. Gatti, B. Cassani, F.A. Caprioli, F. Facciotti, M. Quattrocelli, Y. Torrente
Effect of myofibril architecture on the active contraction of dystrophic muscle. A mathematical model
2021 M. Stefanati, Y. Torrente, J.F. Rodriguez Matas
Behavioral variant of frontotemporal dementia and homicide in a historical case
2021 S. Zago, C. Scarpazza, T. Difonzo, A. Arighi, D. Hajhajate, Y. Torrente, G. Sartori